Status:

WITHDRAWN

Adjuvant Vitamin D With Corticosteroids in Active Crohn's Disease

Lead Sponsor:

Imperial College London

Conditions:

Crohn's Disease

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purpose of this study is to determine whether the addition of vitamin D to standard corticosteroids improves onset of remission in active Crohn's Disease, a form of Inflammatory Bowel Disease (IBD...

Detailed Description

Crohn's Disease is a form of Inflammatory Bowel Disease (IBD). It is caused by abnormal immune-mediated gut inflammation and is both chronic and difficult to treat. Symptoms are often unpleasant (e.g....

Eligibility Criteria

Inclusion

  • Active Crohn's Disease Activity (CDAI) Score \>200 to 450;
  • Diagnosis of IBD and distribution of disease previously confirmed
  • The participant able to give informed consent form;
  • Stable doses of the following concurrent IBD medications prior to inclusion:
  • 5-aminosalicylates (≥4 weeks)
  • Thiopurines (≥8 weeks)
  • No corticosteroids (within 4 weeks)
  • No biological agents (within 8 weeks).

Exclusion

  • Unable to give informed written consent;
  • Co-existence of any other chronic inflammatory conditions
  • Failure to meet concurrent IBD medication criteria;
  • Hypercalcaemia (Corrected serum calcium \> 2.66 mmol/L) or history of vitamin D hypersensitivity;
  • Diagnosis of any of the flowing: active tuberculosis, sarcoidosis, hyperparathyroidism, pseudohyperparathyroidism, nephrolithiasis, silicosis, liver failure, renal failure or malignancy, active TB, sarcoidosis or lymphoma or other granulomatous disease;
  • Known intolerance or contraindication to vitamin D or trial medication (i.e. corticosteroids / infliximab);
  • Biochemical disturbance at enrolment: serum corrected calcium \> 2.66 mmol/L) or serum creatinine \>250 micromol/L;
  • Pregnancy or breast-feeding.

Key Trial Info

Start Date :

May 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2010

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00672763

Start Date

May 1 2008

End Date

May 1 2010

Last Update

June 8 2015

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Imperial College Healthcare NHS Trust (Hammersmith, Charing Cross and St. Mary's Hospitals)

London, London, United Kingdom

2

St. Mark's Hospital

Harrow, Middlesex, United Kingdom